Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (253K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (44)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by De Silva, I. U.
Right arrow Articles by Hartley, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Silva, I. U.
Right arrow Articles by Hartley, J. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2002, Vol. 30, No. 17 3848-3856
© 2002 Oxford University Press

Defects in interstrand cross-link uncoupling do not account for the extreme sensitivity of ERCC1 and XPF cells to cisplatin

Inusha U. De Silva0, Peter J. McHugh0, Peter H. Clingen0 and John A. Hartley*,0

0 Cancer Research UK Drug–DNA Interactions Research Group, Department of Oncology, Royal Free and University College Medical School, 91 Riding House Street, London W1W 7BS, UK

*To whom correspondence should be addressed. Tel: +44 20 7679 9299; Fax: +44 20 7436 2956; Email: john.hartley{at}ucl.ac.uk
Present address:
Inusha U. De Silva, Molecular Haematology and Cancer Biology Unit, Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK

The anticancer drug cisplatin reacts with DNA leading to the formation of interstrand and intrastrand cross-links that are the critical cytotoxic lesions. In contrast to cells bearing mutations in other components of the nucleotide excision repair apparatus (XPB, XPD, XPG and CSB), cells defective for the ERCC1-XPF structure-specific nuclease are highly sensitive to cisplatin. To determine if the extreme sensitivity of XPF and ERCC1 cells to cisplatin results from specific defects in the repair of either intrastrand or interstrand cross-links we measured the elimination of both lesions in a range of nucleotide excision repair Chinese hamster mutant cell lines, including XPF- and ERCC1-defective cells. Compared to the parental, repair-proficient cell line all the mutants tested were defective in the elimination of both classes of adduct despite their very different levels of increased sensitivity. Consequently, there is no clear relationship between initial incisions at interstrand cross-links or removal of intrastrand adducts and cellular sensitivity. These results demonstrate that the high cisplatin sensitivity of ERCC1 and XPF cells likely results from a defect other than in excision repair. In contrast to other conventional DNA cross-linking agents, we found that the repair of cisplatin adducts does not involve the formation of DNA double-strand breaks. Surprisingly, XRCC2 and XRCC3 cells are defective in the uncoupling step of cisplatin interstrand cross-link repair, suggesting that homologous recombination might be initiated prior to excision of this type of cross-link.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Exp BotHome page
K. Abe, K. Osakabe, Y. Ishikawa, A. Tagiri, H. Yamanouchi, T. Takyuu, T. Yoshioka, T. Ito, M. Kobayashi, K. Shinozaki, et al.
Inefficient double-strand DNA break repair is associated with increased fasciation in Arabidopsis BRCA2 mutants
J. Exp. Bot., July 1, 2009; 60(9): 2751 - 2761.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. W. Evans, S. B. Chernikova, L. A. Kachnic, J. P. Banath, O. Sordet, Y. M. Delahoussaye, A. Treszezamsky, B. H. Chon, Z. Feng, Y. Gu, et al.
Homologous Recombination Is the Principal Pathway for the Repair of DNA Damage Induced by Tirapazamine in Mammalian Cells
Cancer Res., January 1, 2008; 68(1): 257 - 265.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. Cobo, D. Isla, B. Massuti, A. Montes, J. M. Sanchez, M. Provencio, N. Vinolas, L. Paz-Ares, G. Lopez-Vivanco, M. A. Munoz, et al.
Customizing Cisplatin Based on Quantitative Excision Repair Cross-Complementing 1 mRNA Expression: A Phase III Trial in Non-Small-Cell Lung Cancer
J. Clin. Oncol., July 1, 2007; 25(19): 2747 - 2754.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. A. Moufarij, D. Sampath, M. J. Keating, and W. Plunkett
Fludarabine increases oxaliplatin cytotoxicity in normal and chronic lymphocytic leukemia lymphocytes by suppressing interstrand DNA crosslink removal
Blood, December 15, 2006; 108(13): 4187 - 4193.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
S. Arnould, V. J. Spanswick, J. S. Macpherson, J. A. Hartley, D. E. Thurston, D. I. Jodrell, and S. M. Guichard
Time-dependent cytotoxicity induced by SJG-136 (NSC 694501): influence of the rate of interstrand cross-link formation on DNA damage signaling.
Mol. Cancer Ther., June 1, 2006; 5(6): 1602 - 1609.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
G. Matullo, S. Guarrera, C. Sacerdote, S. Polidoro, L. Davico, S. Gamberini, M. Karagas, G. Casetta, L. Rolle, A. Piazza, et al.
Polymorphisms/Haplotypes in DNA Repair Genes and Smoking: A Bladder Cancer Case-Control Study
Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2569 - 2578.
[Abstract] [Full Text] [PDF]

Home page
 Plant Physiol.Home page
K. Abe, K. Osakabe, S. Nakayama, M. Endo, A. Tagiri, S. Todoriki, H. Ichikawa, and S. Toki
Arabidopsis RAD51C Gene Is Important for Homologous Recombination in Meiosis and Mitosis
Plant Physiology, October 1, 2005; 139(2): 896 - 908.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
P. H. Clingen, I. U. De Silva, P. J. McHugh, F. J Ghadessy, M. J. Tilby, D. E. Thurston, and J. A. Hartley
The XPF-ERCC1 endonuclease and homologous recombination contribute to the repair of minor groove DNA interstrand crosslinks in mammalian cells produced by the pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136
Nucleic Acids Res., June 8, 2005; 33(10): 3283 - 3291.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
C. P. Diggle, J. Bentley, M. A. Knowles, and A. E. Kiltie
Inhibition of double-strand break non-homologous end-joining by cisplatin adducts in human cell extracts
Nucleic Acids Res., May 4, 2005; 33(8): 2531 - 2539.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
H. I. Abdel-Halim, A. T. Natarajan, L. H. F. Mullenders, and J. J. W. A. Boei
Mitomycin C-induced pairing of heterochromatin reflects initiation of DNA repair and chromatid exchange formation
J. Cell Sci., April 15, 2005; 118(8): 1757 - 1767.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. G. Robison, L. Lu, K. Dixon, and J. J. Bissler
DNA Lesion-specific Co-localization of the Mre11/Rad50/Nbs1 (MRN) Complex and Replication Protein A (RPA) to Repair Foci
J. Biol. Chem., April 1, 2005; 280(13): 12927 - 12934.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
F. Johansson, A. Lagerqvist, K. Erixon, and D. Jenssen
A method to monitor replication fork progression in mammalian cells: nucleotide excision repair enhances and homologous recombination delays elongation along damaged DNA
Nucleic Acids Res., November 10, 2004; 32(20): e157 - e157.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
B. Friedmann, M. Caplin, J. A. Hartley, and D. Hochhauser
Modulation of DNA Repair In vitro after Treatment with Chemotherapeutic Agents by the Epidermal Growth Factor Receptor Inhibitor Gefitinib (ZD1839)
Clin. Cancer Res., October 1, 2004; 10(19): 6476 - 6486.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
F. Koeppel, V. Poindessous, V. Lazar, E. Raymond, A. Sarasin, and A. K. Larsen
Irofulven Cytotoxicity Depends on Transcription-Coupled Nucleotide Excision Repair and Is Correlated with XPG Expression in Solid Tumor Cells
Clin. Cancer Res., August 15, 2004; 10(16): 5604 - 5613.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
R. C.A.M. van Waardenburg, L. A. de Jong, F. van Delft, M. A.J. van Eijndhoven, M. Bohlander, M.-A. Bjornsti, J. Brouwer, and J. H.M. Schellens
Homologous recombination is a highly conserved determinant of the synergistic cytotoxicity between cisplatin and DNA topoisomerase I poisons
Mol. Cancer Ther., April 1, 2004; 3(4): 393 - 402.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
A. Rothfuss and M. Grompe
Repair Kinetics of Genomic Interstrand DNA Cross-Links: Evidence for DNA Double-Strand Break-Dependent Activation of the Fanconi Anemia/BRCA Pathway
Mol. Cell. Biol., January 1, 2004; 24(1): 123 - 134.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. J. Libby, L. G. Reinholdt, and J. C. Schimenti
From the Cover: Positional cloning and characterization of Mei1, a vertebrate-specific gene required for normal meiotic chromosome synapsis in mice
PNAS, December 23, 2003; 100(26): 15706 - 15711.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
C. Spiro and C. T. McMurray
Nuclease-Deficient FEN-1 Blocks Rad51/BRCA1-Mediated Repair and Causes Trinucleotide Repeat Instability
Mol. Cell. Biol., September 1, 2003; 23(17): 6063 - 6074.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
M. L. Fishel, S. M. Delaney, L. D. Friesen, R. J. Hansen, E. G. Zuhowski, R. C. Moschel, M. J. Egorin, and M. E. Dolan
Enhancement of Platinum-induced Cytotoxicity by O6-Benzylguanine
Mol. Cancer Ther., July 1, 2003; 2(7): 633 - 640.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.